QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants

NCT07708272 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: TQ05105 tablets
DRUG: Placebo tablets
DRUG: Moxifloxacin Hydrochloride Tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.